ReviewTherapeutic advances in medical oncology2023

Real-world dose reduction of standard and modified FOLFIRINOX in metastatic pancreatic cancer: a systematic review, evidence-mapping, and meta-analysis.

Kwangrok Jung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.